MAYUKA LABS
Contact Person:
Irbesartan & Intermediates : 1-[(2'-Cyanobiphenyl-4-yl)methyl]-2-n-butyl]-4-spirocyclopentane-2-imidazolin-5-one, 2-n-butyl-4-spirocyclopentane-1-[[2?-(triphenyl methyl tetrazol-5-yl)biphenyl-4-yl]methyl]-2-imidazolin-5-one, Candesartan & Intermediates : 2-Chloro-3-nitro-benzoic acid ethyl ester, Ethyl-2-[4-Bromobenzylamine]-3-nitro benzoate, Ethyl-(3-amino-2-(4-bromobenzylamine) benzoate, Ethyl 1-(4-bromobenzylamine)-2-ethoxy benzimidazole-7-carboxylate, Ethyl 2-ethoxy-1-[[2?-(1H-tetrazole-5-yl]-1-1?-biphenyl-4yl] methyl] 1H-benzimidazole-carboxylate, Valsartan Intermediates : 4?-Bromomethyl-1,1?-biphenyl-2-carbonitrile, N[2'-Cyano biphenyl-4-yl)methyl]-L-valine methyl ester oxalate salt, Telmisartan Intermediates : 3-Methyl-4-butyrylamino-5-nitro acetophenone, 3-Methyl-4-butyrylamino-5-nitro-1-bromo acetophenone, 2-Butyrylamino-3-nitro-5-(benzimidazole-2-yl) toluene, 2-Butyrylamino-3-nitro-5-(1-methyl benzimidazole-2-yl) toluene, 2-Butyrylamino-3-amino-5-(1-methyl benzimidazole-2-yl) toluene, 2-Propyl-4-methyl-6-(1-methyl-2-benzimidazolyl) benzimidazole, Methyl-4?-[(2-propyl-4-methyl-6-(1-methyl-2-benzimidazolyl)-benzimidazole-1-yl) methyl]-biphenyl-2-caboxylate hydrochloride, Eprosartan & Intermediates : 2-n-Butyl-5-hydroxymethyl imidazole, 2-n-Butyl-5-aldehyde-1H imidazole, 2-n-Butyl-1-Pivaloxy methyl imidazole-5-aldehyde, 2-n-Butyl-1[(4-carboethoxy phenyl) methyl]imidazole-5-aldehyde, Tri methyl-3(2-thienyl)-2-phospheno propionate, E-(3)-2-n-Butyl-1(4-Ethoxy carbonyl phenyl) methyl-1H-imidazole-5-yl (2-thienyl) methyl (2-propionate), Sumatriptan & Intermediates : 1-(Chloromethyl)-4-Nitrobenzene, Sodium (4-nitrophenyl)-methane Sulfonate, (4-Nitrophenyl)-methane sulphonyl chloride, N-Methyl-4-Nitrobenzene methane sulphonamide, 4-Amino-4-methyl benzene methane sulphonamide hydrochloride, 4-Hydrazino-N-methyl benzene methane sulphonamide hydrochloride, 4-[2-(3-Cyano propylidine) hydrazino] benzene methane sulphonamide, 3-(Cyanomethyl)-1H-indole-5-methane sulphonamide, 3-[2-(Dimethyl amino) ethyl)-1H-indol-5-methane sulphonamide, Zolmitriptan & Intermediates : (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one, (S)-4-(4-aminobenzyl)-2-oxazolidinone, (S)-4-(4-Aminobenzyl)-1,3-oxazolidin-2-one, 4,4-Diethoxy-N, N-dimethyl-butylamine, Methyl-4-nitro-L-phenylalanate monohydrochloride, Rizatriptan & Intermediates : 4-(1H-1,2,4-Triazole-1-yl-methyl)phenyl hydrazine dihydrochloride, 1H-1-[(4-Aminophenyl)methyl]-[1,2,4]-triazole, Naratriptan & Intermediate : N-Methyl ethane sulfonamide, 2-(1-Methyl-4-piperidinyl)-acetaldehyde, N-Methyl-1H-indole-5-ethane sulfonamide, 2-Chloro ethane sulfonyl chloride, Montelukast API (Non Infringing), Montelukast Intermediates : ML5 {3-[(E)-2(7-chloro-quinolin-2-yl)-vinyl]-phenyl}-3-[2-(1-hydroxy-1-methyl-ethyl)-phenyl]-propan-1-ol (CAS : 142569-70-8), ML3 2-(3-{3-[2-(7-Chloro-quinolin-3-yl)-vinyl]-phenyl}-3-oxo-propyl)-benzoic acid methyl ester (CAS : 181139-72-0), ML4 Methyl-2-3-(S)-(3-(2-7-chloro-2-quinolinyl)-ethenyl)phenyl)-3-hydroxypropyl)benzoate (CAS : 181139-72-0), MS4 [1-(mercaptomethyl)cyclopropyl]acetic acid (CAS : 162515-68-6), ML13 (R)-(E)-1-[[[-1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy1methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid, (CAS : 158966-92-8 )(Montelukast acid), MS2 2-[1-(Hydroxymethyl)-cyclopropyl]-acetonitrile, Grignard Reagents : Vinyl Magnesium Bromide, Vinyl Magnesium Chloride, Methyl Magnesium Bromide, Methyl Magnesium Chloride, Ethyl Magnesium Chloride, Ethyl Magnesium Bromide, Allyl Magnesium Chloride, Boronic Acids : 3-Nitrophenyl boronic acid (CAS : 13331-27-6), Phenyl boronic acid, 3-Fluorophenyl boronic acid (CAS : 768-35-4), 4-Flurophenyl boronic acid, 4-Cyanomethylphenyl boronic acid (CAS : 91983-26-5), 4-Methoxy phenyl boronic acid, 4-Ethylphenyl boronic acid (CAS : 63139-21-9), 4-Ethoxy phenyl boronic acid, 4-Hydroxyphenyl boronic acid (CAS : 71597-85-8), Isobutyl boronic acid, 3,5-Dimethoxyphenyl boronic acid (CAS : 192182-54-0), 3-Trifluoromethoxyphenyl boronic acid (CAS : 179113-90-7), tris(Pentafluorophenyl) borane (CAS : 1109-15-5), Speciality Chemicals : Di ethyl zinc (CAS : 557-20-0), Di ethyl methoxy borane (CAS : 7397-46-8), Di iso butyl aluminium hydride (CAS : 1191-15-7), Tri ethyl borane (CAS : 97-94-9), (-)Diisopinocampheylchloroborane, 18-Crown-6 (CAS : 17455-13-9), 15-Crown-5 (CAS : 33100-27-5), Dibenzo-18-Crown-6 (CAS : 14187-32-7), Effavirenz & Intermediates : 4-Chloroaniline, N-(4-Chlorophenyl)-2,2-dimethyl propanamide, 1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoroethanone, 2-(2-Amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol, (4S)-6-Chloro-4-(cyclopropyl ethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one (EFAVIRENZ), Modafinil, Topiramate & Intermediates, Rupatadine Fumerate, Biperiden Hydrochloride, Phosgene Based Intermediates, Products Under Development : Atorvastatin, Posaconazole, Fondaparinux, Sitaglibtin, Silomilast, Solifenacin, Aliskirene, Rameltoen, Divalproex, Darifenacin, Entacavir, Glatiramer, Ritonavir, Nevirapine, Olmesartan, Latanoprost, Eplerenone, Prasugrel